Indianapolis, Indiana-based Elevance Health, Inc. (ELV) operates as a health benefits company in the United States. The company has a market cap of $83.4 billion and operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individuals and employer groups, including risk-based and fee-based plans, BlueCard, Medicare, Medicaid, and others.
ELV is expected to release its Q2 2026 earnings soon. Ahead of the event, analysts expect the company’s EPS to be $6.18 on a diluted basis, down 30.1% from $8.84 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in three of its last four quarters, while missing on one occasion.